Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation.
van der Horst SFB, de Vries TAC, Chu G, Bavalia R, Xiong H, van de Wiel KM, Mulder K, van Ballegooijen H, de Groot JR, Middeldorp S, Klok FA, Hemels MEW, Huisman MV. van der Horst SFB, et al. Among authors: hemels mew. TH Open. 2023 Sep 27;7(3):e270-e279. doi: 10.1055/a-2161-0928. eCollection 2023 Jul. TH Open. 2023. PMID: 37772087 Free PMC article.
Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial.
Joosten LPT, van Doorn S, Hoes AW, Nierman MC, Wiersma NM, Koek HL, Hemels MEW, Huisman MV, Roes KC, van den Bor RM, Buding WF, Rutten FH, Geersing GJ. Joosten LPT, et al. Among authors: hemels mew. BMJ Open. 2019 Dec 29;9(12):e032488. doi: 10.1136/bmjopen-2019-032488. BMJ Open. 2019. PMID: 31888928 Free PMC article.
Temporal patterns and short-term progression of paroxysmal atrial fibrillation: data from RACE V.
De With RR, Erküner Ö, Rienstra M, Nguyen BO, Körver FWJ, Linz D, Cate Ten H, Spronk H, Kroon AA, Maass AH, Blaauw Y, Tieleman RG, Hemels MEW, de Groot JR, Elvan A, de Melis M, Scheerder COS, Al-Jazairi MIH, Schotten U, Luermans JGLM, Crijns HJGM, Van Gelder IC; RACE V Investigators. De With RR, et al. Among authors: hemels mew. Europace. 2020 Aug 1;22(8):1162-1172. doi: 10.1093/europace/euaa123. Europace. 2020. PMID: 32642768 Free PMC article.
Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation.
Chu G, Seelig J, Trinks-Roerdink EM, van Alem AP, Alings M, van den Bemt B, Boersma LV, Brouwer MA, Cannegieter SC, Ten Cate H, Kirchhof CJ, Crijns HJ, van Dijk EJ, Elvan A, van Gelder IC, de Groot JR, den Hartog FR, de Jong JS, de Jong S, Klok FA, Lenderink T, Luermans JG, Meeder JG, Pisters R, Polak P, Rienstra M, Smeets F, Tahapary GJ, Theunissen L, Tieleman RG, Trines SA, van der Voort P, Geersing GJ, Rutten FH, Hemels ME, Huisman MV. Chu G, et al. BMJ Open. 2020 Aug 24;10(8):e036220. doi: 10.1136/bmjopen-2019-036220. BMJ Open. 2020. PMID: 32843516 Free PMC article.
Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands: insights from the ETNA-AF-Europe study.
de Vries TAC, Hemels MEW, Cools F, Crijns HJGM, Yperzeele L, Vanacker P, Blankoff I, Lancellotti P, Mairesse GH, de Veer A, Casado Arroyo R, Catez E, de Pauw M, Vanassche T, de Asmundis C, Kirchhof P, De Caterina R, de Groot JR; ETNA-AF-Europe principal investigators from Belgium and the Netherlands. de Vries TAC, et al. Among authors: hemels mew. Acta Cardiol. 2021 Jun;76(4):431-439. doi: 10.1080/00015385.2020.1746095. Epub 2021 Jan 7. Acta Cardiol. 2021. PMID: 33406996 Free article.
98 results